Go Pro
NASDAQ:ABP

Abpro Q2 2025 Earnings Report

Abpro logo
$0.52 0.00 (0.00%)
As of 06/26/2026

Abpro EPS Results

Actual EPS
-$1.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Abpro Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Abpro Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Abpro Earnings Headlines

Abpro Holdings Faces Nasdaq Delisting, Moves to OTC
Abpro Holdings Directors Resign, Board Seeks Replacements
Buy the “unseen winner of the AI race” before July 22
Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split into three separate companies in a rare event called a 'starburst' before July 22. Investors who buy shares before the announcement could automatically receive equal shares in each spinoff. A similar starburst at GE unlocked $184 billion for shareholders across three new companies.tc pixel
ABPO Abpro Holdings, Inc.
Abpro Bio Co. Ltd.
See More Abpro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abpro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abpro and other key companies, straight to your email.

About Abpro

Abpro (NASDAQ:ABP) is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

View Abpro Profile